This Is America’s Biggest Financial Fear
More than 60 percent of Americans are losing sleep at night because of financial concerns, and the biggest concern is that they’re not saving enough for retirement, according to a new report from CreditCards.com.
The second-biggest worry is about the cost of education, with half of those between the ages of 18 and 29 saying that concern keeps them up at night.
The percentage of Americans worried about education costs has been growing for the past eight years and is the only category that has become a bigger problem since the Great Recession. “Unless something slows the rapid rise in college costs, this could soon be Americans’ biggest financial fear,” CreditCards.com senior analyst Matt Schultz said in a statement.
Related: 12 Smart Money Moves Millennials Should Make Right Now
That echoes a Gallup poll released in April, which found that 73 percent of parents with kids under age 18 ranked paying for college as a financial worry, more than were concerned about saving for retirement or covering medical expenses.
Nearly one in three Americans are losing sleep because of medical bills, 27 percent are worried about their mortgage or rent payment, and 21 percent fret over credit card debt.
Older Americans and those with higher incomes seem to have fewer financial anxieties than younger generations. Less than half of those age 65 or older are losing sleep over their finances, versus more than two thirds of adults 64 or younger. Of those making less than $75,000 per year, 69 percent had financial worries, compared to just 51 percent of those making more than $75,000.
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
